Neuropathic Pain Market Forecast 2011

Report Summary

At present, only six drugs are indicated for the treatment of neuropathic pain. In 2010, two significant events impacted the neuropathic pain market: the launch of Qutenza (8% capsaicin patch; NeurogesX/Astellas) in the US and EU; and the high-profile failure of ralfinamide (NW-1029; Newron) for the treatment of neuropathic low back pain.In depth analysis of historic (2005–09) and future (2010–19) seven major market prescription sales dynamics.Includes neuropathic pain and country-specific sales forecasts for key brands, generics and pipeline drugs in the seven major markets to 2019.The neuropathic pain market is expected to achieve peak sales of $4.1bn over the forecast period (2010–19) across the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK).In addition to existing brands expanding into new regions, Datamonitor forecasts a total of eight pipeline candidates to enter the neuropathic pain market over the forecast period (2010–19) across the seven major markets.The broad label approval of Nucynta ER (extended-release tapentadol; Johnson & Johnson/Grünenthal) will drive market growth, while the launch of novel and topical agents will broaden treatment options.What will be the impact of major generic launches to the neuropathic pain market and what are the implications to prospective players?What are the most promising drug candidates in development for the potential treatment of neuropathic pain?What is the expected uptake of topical reformulations for neuropathic pain?What is the commercial potential of Qutenza (8% capsaicin patch; NeurogesX/Astellas) following its 2010 launch?

Table Of Contents

OVERVIEW

Summary

OVERVIEW
This product contains forecasts for neuropathic pain drugs across the seven major markets from 2010 to 2019. It has been designed for delivery in an excel data pack format, but for more detail about this disease area please see the accompanying Pipeline and Commercial Insight: Neuropathic Pain Word document and PowerPoint executive presentation (HC00019-001).
The associated report and PowerPoint presentation can be found under Latest research in the Knowledge centre, through the search function or by contacting your sales representative.
Please select the data pack option from the download menu at the side of the page to access the model.
Introduction
Highlights
Features and benefits
Your key questions answered
Forecasting Methodology
The forecasting model:
General event information:
Event selection and quantification:
Event parameters:
Disclaimer